SECOND AMENDMENT TO AMENDED AND RESTATED FINANCING AGREEMENTFinancing Agreement • April 12th, 2013 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledApril 12th, 2013 Company Industry JurisdictionThis SECOND AMENDMENT TO AMENDED AND RESTATED FINANCING AGREEMENT (this “Amendment”) is made and entered into as of April 8, 2013 by and among Unigene Laboratories, Inc., a Delaware corporation (“Principal Borrower”), the financial institutions party hereto as “Lenders” (collectively, “Lenders”), and Victory Park Management, LLC, as administrative agent and collateral agent (in such capacity, “Agent”) for Lenders and the Holders (as defined in the Financing Agreement (as defined below)); all capitalized terms used and not otherwise defined herein and in the Exhibits shall have the respective meanings ascribed to them in the Financing Agreement or, if not defined in the Financing Agreement, the respective meanings ascribed to them in the Notes (as defined below).